Venus Remedies vancoplus product gets patent from South Africa & New Zealand - Patents.
Venus Remedies has received patent for vancoplus product, one of the key research product of Venus used to combat Methilicillin Resistant Staphylococcus Aureus (MRSA), from Replublic of South Africa and New Zealand. Vancoplus is a brand of ceftriaxone and vancomycin along with chemical vector used in CVMC technology which has a potential to restrict production of toxin produced by MRSA. Vancoplus therapy reduces treatment time and cost and is a boon for medical field.
